Boston Scientific
BSX
558 hedge funds and large institutions have $34.8B invested in Boston Scientific in 2017 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 210 increasing their positions, 204 reducing their positions, and 44 closing their positions.
49% more call options, than puts
Call options by funds: $65M | Put options by funds: $43.8M
23% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 44
10% more capital invested
Capital invested by funds: $31.5B → $34.8B (+$3.28B)
1% more funds holding
Funds holding: 552 → 558 (+6)
3% more repeat investments, than reductions
Existing positions increased: 210 | Existing positions reduced: 204
0.93% less ownership
Funds ownership: 92.6% → 91.67% (-0.93%)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$1.03B |
| 2 |
Jennison Associates
New York
|
+$226M |
| 3 |
BlackRock
New York
|
+$118M |
| 4 |
JP Morgan Chase
New York
|
+$81.8M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$80.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$277M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$154M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$154M |
| 4 |
AIM
abrdn Investment Management
Edinburgh,
United Kingdom
|
-$114M |
| 5 |
Millennium Management
New York
|
-$111M |
BSX Hedge Fund Activity: Q2 2017 in Review
558 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2017, worth a combined $34.8B — up 10% from $31.5B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new BSX positions and 44 closed out — a net gain of 10 holders — while 210 added to existing stakes and 204 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $1.03B. The largest seller was Fidelity Investments, cutting an estimated $277M.
- 558 institutional investors held Boston Scientific (BSX) as of Q2 2017, up from 552 in Q1 2017.
- Funds reported $34.8B of Boston Scientific stock for Q2 2017, up 10% quarter-over-quarter.
- 54 funds opened new Boston Scientific positions in Q2 2017 and 44 closed out, a net change of +10 holders.
- The largest Boston Scientific buyer in Q2 2017 was Janus Henderson Group, an estimated $1.03B added.
- The largest Boston Scientific seller in Q2 2017 was Fidelity Investments, an estimated $277M sold.
Based on aggregated 13F filings for Q2 2017.